Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Histogen Inc (HSTO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...
On Friday, shares of Histogen Inc HSTO experienced volatile short activity. After the activity, the stock price went up +54.24% to $1.33. The overall sentiment for HSTO has been Bullish. The signal ...
SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO, the “Company” or “Histogen”), a drug development company for treatment of bacterial skin infections, today announced that it has ...
Short interest in Histogen Inc COM NEW (OTC:HSTO) decreased during the last reporting period, falling from 1.12K to 1.12K. This put 0.03% of the company's publicly available shares short. Short ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback